Determination of related substances in ketoprofen injection by RP-HPLC method

被引:0
作者
Luo, Lei [1 ]
Tan, Mingguo [1 ]
Luo, Yonghuang [1 ]
机构
[1] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
RP-HPLC; ketoprofen; injection; related substances;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The paper aims to establish a RP-HPLC method for the simultaneous determination of six related substances in ketoprofen injection. The separation was performed on a VP-ODS C-18 column (4.6mmx250mm, 5 mu m) with the mobile phase of 6.8% phosphate buffer solution (adjusted to pH3.5 with 85% phosphoric acid)-acetonitrile-water (2:43:55,v/v/v) at a flow rate of 1.2mL.min(-1). The detection wavelength and the injection volume were set at 233nm and 20 mu L, respectively. Impurity A and C were calculated by external standard method. Main component self-compare method with calibration factor was used to calculate impurity B, D, E, F and main component self-compare method without calibration factor was used to calculate unspecified impurity. Related substances and degraded substances were completely separated from ketoprofen. For impurity A and C, the linear range of determination were separately 0.06 mu g.mL(-1)similar to 3.6 mu g.mL(-1) and 0.036 mu g.mL(-1)similar to 2.4 mu g.mL(-1) with the correlation coefficient of 0.9999. The average recoveries (n=9) were 98.13% (RSD=0.35%) and 96.32% (RSD=0.43%). The precision and repeatability for method were good. With reference to ketoprofen (retention time =10.06 min), the relative retention time of impurity B, D, B, F were 0.71, 1.46, 0.59, 2.13, respectively, and the relative correction factors were 0.962, 0.938, 0.957, 0.960, respectively. Finally, determined that the contents of impurity A could not be more than 0.3%, any of the contents of impurity B, C, D, E, F and unspecified impurities could not be more than 0.2%, sum of the contents of impurities other than A and C couldn't be more than 0.5%. The method was proved to be simple, rapid, accurate, sensitive and suitable for the simultaneous determination of six related substances in ketoprofen injection.
引用
收藏
页码:1607 / 1614
页数:8
相关论文
共 14 条
[1]  
British Pharmacopoeia, 2012, BRIT PHARM, P2318
[2]  
Chinese Pharmacopoeia, 2010, CHIN PHARM, P1065
[3]   Ketoprofen Inhibits Expression of Inflammatory Mediators in Human Dental Pulp Cells [J].
Choi, Eun-Kyoung ;
Kim, Sun-ho ;
Kang, In-Chol ;
Jeong, Ji-Yeon ;
Koh, Jeong-Tae ;
Lee, Bin-Na ;
Oh, Won-Mann ;
Min, Kyung-San ;
Nor, Jacques E. ;
Hwang, Yun-Chan .
JOURNAL OF ENDODONTICS, 2013, 39 (06) :764-767
[4]   Simultaneous HPLC determination of ketoprofen and its degradation products in the presence of preservatives in pharmaceuticals [J].
Dvorák, J ;
Hájková, R ;
Matysová, L ;
Nováková, L ;
Koupparis, MA ;
Solich, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 36 (03) :625-629
[5]  
El-Baz M. A., 1995, International Urology and Nephrology, V27, P245, DOI 10.1007/BF02564757
[6]  
Guo HX, 2001, HIGH ENERG PHYS NUC, V25, P1
[7]  
Imad K, 2012, HDB DRUG INTERACTION, P415
[8]  
Liao YW, 1997, CHIN J PHARM, V9, P387
[9]  
Lv B, 2000, CHIN J MED CHEM, V10, P127
[10]   ACECLOFENAC IN COMPARISON TO KETOPROFEN IN THE TREATMENT OF RHEUMATOID-ARTHRITIS [J].
MARTINMOLA, E ;
GIJONBANOS, J ;
ANSOLEAGA, JJ .
RHEUMATOLOGY INTERNATIONAL, 1995, 15 (03) :111-116